Indegene IPO: A Look at the Subscription Status and Upcoming Listing

Indegene IPO Fully Subscribed on First Day of Issue

The much-anticipated Initial Public Offering (IPO) of Indegene, a global leader in healthcare solutions, got off to a flying start as it was fully subscribed on its first day of trading, May 6, 2024. The IPO garnered significant interest from investors eager to capitalize on the company’s promising prospects in the rapidly evolving healthcare industry.

Price Band and Lot Size

The issue price for the Indegene IPO was set in the range of ₹430 to ₹452 per share, offering investors an opportunity to acquire stakes in the company at an attractive valuation. The minimum order quantity, or lot size, was set at 33 shares, allowing both retail and institutional investors to participate in the offering.

Listing and Trading Expectations

With the IPO oversubscribed on its first day, market analysts anticipate a strong debut for Indegene on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). The company’s shares are expected to list on Monday, May 13, 2024, providing investors with an early opportunity to trade and capitalize on the potential upside.

Offer Details and Subscription Status

The Indegene IPO was a book-built issue with a total size of ₹1,841.76 crores, comprising a fresh issue of ₹760 crores and an offer for sale (OFS) of ₹1,081.76 crores by selling shareholders. The offering attracted strong interest across investor categories, with non-institutional investors subscribing 4.13 times, retail investors 1.50 times, and employees 1.31 times. However, qualified institutional buyers subscribed to only 5% of the offering.

Investor Confidence and Market Sentiment

The overwhelming response to the Indegene IPO underscores investor confidence in the company’s business model, growth prospects, and management team. As the healthcare industry continues to witness rapid transformation driven by technological advancements and changing consumer behavior, Indegene is well-positioned to capitalize on emerging opportunities and deliver sustainable value to its shareholders.


The successful subscription of the Indegene IPO reaffirms the company’s status as a leading player in the global healthcare solutions market. With a fully subscribed offering and strong investor interest, Indegene is poised for a successful listing on the stock exchanges, paving the way for its next phase of growth and expansion. As investors eagerly await the commencement of trading, all eyes will be on Indegene as it embarks on its journey as a publicly listed company.

Leave a Reply

Your email address will not be published. Required fields are marked *